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Abnormal cytoplasmic pH regulation during activation in uremic
neutrophils. Neutrophils isolated from ESRF patients demonstrated
abnormal cytoplasmic pH changes after FMLP stimulation; the initial
cytoplasmic acidification was absent (P < 0.001 compared to controls)
and the degree of alkalinization enhanced (P < 0.05 compared to
controls). This effect was not due to the absence of any of the factors
associated with acidification in normal PMN since superoxide produc-
tion was enhanced (P < 0.05 compared to controls) and intracellular
calcium release was normal. Our observations are not explicable by
alterations in the function of the Na:H antiport since the kinetics of
antiport activation by cytoplasmic pH were not different in uremic and
control cells. Other factors must therefore be important in generating
the abnormal pH response to chemotactic factors in uremic PMN. Cells
from CAPD patients had some degree of initial acidification (P < 0.001
compared to controls and P < 0.05 compared to ESRF) and enhanced
alkalinization (P < 0.05 compared to controls). Preincubation of normal
PMN in four-hour dwell PDE reproduced the responses of uremic PMN
with absent acidification, enhanced alkalinization and enhanced super-
oxide generation after FMLP stimulation (P < 0.05 compared to
controls). Changes in the control of cytoplasmic pH in stimulated PMN
may influence PMN function, and our observations may be relevant to
the susceptibility of uremic patients to infection.
Infection remains a common cause of morbidity and mortality
in patients with end-stage renal failure (ESRF) [1, 21. The
pathogenesis of this susceptibility to infection is likely to be
complex with abnormalities described in a variety of host
defence mechanisms [3—71, but pyogenic infection is common in
uremia providing in vivo evidence of defective phagocytic cell
function. Consequently, the study of phagocyte function is
relevant to the development of an understanding of uremia.
Previous studies have demonstrated that the ability of circulat-
ing neutrophils (PMN) to kill ingested micro-organisms is
depressed in end-stage renal failure [8, 9]. This defect is
reproduced in normal PMN by incubation in used peritoneal
dialysis fluid (PDE) from patients receiving continuous ambu-
latory peritoneal dialysis [9]. Dialysable toxins accumulating in
uremia may therefore interact adversely with circulating PMN.
Normal intracellular killing by PMN requires the interaction of
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oxidants generated by the respiratory burst and products re-
leased into the phagosome by degranulation [reviewed in 10,
11]. Well-described biochemical changes accompany PMN ac-
tivation, and these are important for the control of degranula-
tion and the respiratory burst. These include changes in intra-
cellular calcium levels and cytoplasmic pH. In this paper we
report our observations upon the changes in these parameters
accompanying activation in uremic PMN.
Methods
Subjects
Fourteen patients with end-stage renal failure (ESRF), hence
plasma creatinine > 500 LM/liter (mean 719 M 57, 8.12 mg%
0.64) and not yet receiving renal replacement therapy were
studied. There were nine males and five females with a median
age of 58 years (range 23 to 78 years). Patients with underlying
disease known to be associated with abnormal PMN function,
such as diabetes mellitus or systemic lupus erythematosus,
were excluded. All patients had given informed consent and
none had received antibiotics or blood transfusion in the month
prior to study.
Eleven patients established on continuous ambulatory pen-
toneal dialysis (CAPD) for two months or longer were studied
(mean creatinine 934 iM 91, 10.55 mg% 1.03). There were
six males and five females with a median age of 63 years (range
33 to 75 years). All patients were uninfected at the time of study
and none had received antibiotics or blood transfusion in the
month prior to study. All patients had given informed consent
and as above, patients with underlying disease associated with
abnormal PMN function were excluded.
Control cells were obtained from healthy volunteers.
Peritoneal dialysis effluent
Effluent peritoneal dialysate (PDE) was obtained after four
hour dwells of 1.36% dialysis solution (Dianeal, Baxter Trave-
no! Inc. Chicago, Illinois, USA). All PDE studied were from
patients established on CAPD for greater than two months who
had not received antibiotics in the month prior to study. All
PDE were filtered through a 0.2 M pore filter and used fresh.
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Isolation of cells
Whole blood was anticoagulated in EDTA (final concentra-
tion 3.01 mM). Neutrophils were isolated by Dextran sedimen-
tation and centrifugation over sodium metrizoate-Ficoll as
previously described [12]. Isolated cells were washed twice,
resuspended in Hanks balanced salt solution (HBSS) with 20
mM Hepes (pH 7.4) and counted in a haemocytometer. Cell
viability was confirmed to be greater than 99% by Trypan blue
exclusion.
Measurement of cytoplasmic pH
Cytoplasmie pH was measured using the fluorescent probe
2' ,7' bis(carboxyethyl)-5(and -6) carboxyfluorescein (BCECF,
Calbiochem, California, USA) essentially as described by Grin-
stein and Furuya [13] and Faucher and Naccache [14]. Briefly,
PMN suspensions in HBSS with 20 mrt Hepes (pH 7.4, 1 X io
cells/ml) were incubated with 5 LM acetylmethoxy BCECF for
five minutes at 37°C with end over end rotation. Cells were then
peileted by centrifugation, resuspended and incubated for a
further 15 minutes at room temperature. For pH measurement,
cells were diluted to 2 x 106/ml in HBSS with 20 mrvi Hepes and
placed in a 37°C thermostatted cuvette in a fluorimeter (Kon-
tron Instruments, Zurich, Switzerland). Fluorescence was re-
corded as the ratio of the emission recorded at 530 nm for pH
sensitive (500 nm) and pH insensitive (440 nm) excitation
wavelengths. The stimulus FMLP was added after a stable
baseline reading was reached. The fluorescent signal was cali-
brated by exposing the cells to nigericin in the presence of
buffer solutions of known pH as previously described [15, 16].
Results are expressed with the baseline pH normalized to zero.
Intracellular acidification, buffering capacity and recovery
from acid loading
Cells were loaded with BCECF as above but resuspended in
sodium-free choline chloride buffer, and instead of stimuli 1 tM
nigericin was added to acid load the cytoplasm. A variety of
intracellular pH levels were obtained by adding defatted bovine
serum albumin (final concentration 5 mg/mi) to scavenge the
nigericin and halt acidification [17]. Each aliquot of cells was
then divided into three and the cells peiieted in a microfuge.
One aliquot was resuspended in 50 sl HBSS containing Hepes
(pH 7.4) with the nominal absence of bicarbonate, and the initial
linear recovery from acidification recorded over 30 seconds by
monitoring BCECF fluorescence as described above. A second
aliquot was resuspended in HBSS containing 4.2 mM/liter
sodium bicarbonate and the recovery from acid loading re-
corded as described above. The remaining cells were resus-
pended in 50 d sodium-free choline chloride buffer to deter-
mine the intracellular buffering capacity at the same starting pH
as the measurements for recovery from acid loading [18]. This
was achieved by recording the BCECF fluorescence as de-
scribed above after adding aS m pulse of ammonium chloride.
The buffering capacity was calculated as previously described
by measuring the increase in cytoplasmic pH above baseline in
the presence of ammonium chloride [191. The rate of recovery
from acid loading was calculated from the product of the
buffering capacity and the increase in pH over the first 30
seconds after acid loading, both being measured from the same
starting cytoplasmic pH [18]. In bicarbonate free conditions,
the recovery from acid loading reflects the activity of the
plasma membrane Na:H antiport hence is absent in sodium free
media. The rate of recovery from acid loading in bicarbonate
free conditions thus provides a measure of the variation in
Na:H antiport kinetics with intracellular pH.
Intracellular calcium measurement
Changes in intracellular free calcium were measured using
the fluorescent probe Fura 2 as previously described [20, 211.
Briefly, PMN were suspended at 1 x 107/ml in HBSS with 20
mM Hepes and incubated with 1 M acetylmethoxy Fura 2 for
30 minutes at 37°C with end over end rotation. Cells were
washed free of extracellular probe, resuspended at 2 x 106/ml
and equilibrated for a further 10 minutes at 37°C. Loaded cells
were transferred to the thermostatted cuvette of a fluorimeter
(Kontron Instruments, Zurich, Switzerland). Fluorescence sig-
nals were monitored with an excitation wavelength of 340 nm
and emission recorded at 510 nm. The stimulus FMLP was
added after a stable baseline was obtained. Changes in fluores-
cence were calibrated at the end of each experiment as previ-
ously described [22].
Superoxide measurement
Superoxide production was monitored by measuring lucige-
nm enhanced chemiluminescence production in a LKB Wallac
1251 Luminometer as previously described [23]. Briefly, PMN
were suspended in phosphate buffered saline (PBS) containing
calcium (1.0 mM/liter), magnesium (0.7 mM/liter) and 0.1%
bovine serum albumin. Cells were placed in a thermostatted
compartment with lucigenin (final concentration 25 sM). The
stimulus FMLP was added and the superoxide production
monitored by measuring the total light emitted over the speci-
fied time and subtracting that of unstimulated control cells.
Chemicals
BCECF (Calbiochem) was stored aliquotted as a 1 m stock
solution in DMSO under an inert atmosphere and dessicated at
—20°C.
Fura 2 (Calbiochem) was aliquotted as a 1 m stock solution
in DMSO, sonicated and stored under an inert atmosphere
dessicated at —20°C. Each new batch of acetylmethoxy Fura 2
was tested for the presence of partially de-esterified forms as
described by Scanlon, Williams and Fay [24].
The amiloride analogue 5-(N,N-hexamethylene)amiloride
(supplied by Dr. A. Knox, Respiratory Medicine Unit, City
Hospital, Nottingham, UK) was dissolved in DMSO and diluted
in aqueous buffer immediately before use.
All other chemicals were purchased from Sigma Chemical
Company (Poole, Dorset, UK).
All chemicals dissolved in DMSO were used in final dilutions
which ensured a final concentration of DMSO less than 0.05%.
Buffers
The following buffer solutions were used:
Hanks balanced salt solution (all mM/liter). NaC1 136, KC1
5.4, CaC12 1.3, MgSO4 0.8, KH2PO4 0.4, Dextrose 5.6 and
Na2HPO4 0.4 with 20 mM Hepes (pH 7.4).
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Table 1. Demographic data for uremic subjects
Uremic patients
ESRF CAPD(N 14) (]V= 11)
Creatinine /.LM/ljter 719 57 934 91
Sodium mM/liter 138.2 1.4 138.5 0.9
Potassium mM/liter 4.4 0.2 4.4 0.1
Calcium mM/liter 2.1 0.1 2.4 0.1
Phosphate mM/liter 2.1 0.1 2.0 0.1
Albumin gluIer 38.7 1.0 34.8 1.9
Bicarbonate mM/liter 16.0 1.5 21.0 2.4
Alkaline phosphatase IU 260 45 228 39
Haemoglobing/dl 8.3 0.5 9.1 0.7
Hanks balanced salt solution with bicarbonate (all mM/liter).
NaCI 132, KC1 5.4, CaC12 1.3, MgSO4 0.8, KH2PO4 0.4,
Dextrose 5.6, NaHCO3 4.2 and Na2HPO4 0.4 with 20 mi Hepes
(pH 7.4).
pH calibration solution (all mM/liter). KC1 120 with 20 mM
Hepes and the pH adjusted to the desired level by adding dilute
HC1 or NaOH.
Choline buffer (all mM/liter). Prepared as above but with
isosmotic replacement of NaC1 by choline chloride.
Phosphate buffered saline (all mM/liter). NaCI 137, Na2HPO4
8.0, KH2PO4 1.47 and KCI 2.68 (pH 7.4).
All buffers were prepared fresh and their pH checked prior to
use.
Statistics
Standard error of the mean was used as a measure of variance
and statistical comparisons were made using the Mann Whitney
U test.
Results
The demographic data for the uremic patients are included in
Table 1. The two groups studied were not different in terms of
age and sex distribution, hemoglobin, medication or the under-
lying cause of their renal disease. The CAPD group had a
significantly elevated steady-state creatinine compared to
ESRF patients (P < 0.05).
Cytoplasmic pH responses of stimulated uremic PMN
The resting cytoplasmic pH of cells from ESRF and CAPD
patients was not significantly different from that of control cells
(Table 2). These values are in agreement with those published
by other authors using the BCECF and other techniques [25,
26]. Normal cells stimulated with the chemotactic peptide
FMLP (1O_6 M) demonstrated a biphasic cytoplasmic pH re-
sponse; an initial rapid acidification of approximately 0.05 pH
units was followed by a sustained alkalinization to approxi-
mately 0.15 pH units above baseline by 140 seconds after
stimulation (Fig. la). These changes are in agreement with
those reported by other authors [25—28].
Cells from ESRF patients demonstrated a markedly abnormal
pH response after FMLP stimulation (Fig. La). The initial
acidification was consistently absent (P < 0.001 for 30 second
time point compared to controls) and the degree of alkaliniza-
tion at 140 seconds after stimulation enhanced (P < 0.05
compared to control), Cells from CAPD patients demonstrated
Table 2. Basal cytoplasmic pH values
Subjects Basal pH N
Control
ESRF
CAPD
Control + PDE
6.82 0.068
7.00 0.091
6.91 0.060
6.81 0.054
(22)
(14)
(11)
(22)
Data are presented as the mean SEM of the number of subjects in
parentheses.
similar abnormalities with a reduced degree of initial acidifica-
tion (P < 0.05 compared to controls and P < 0.05 compared to
ESRF at 20 seconds after stimulation, Fig. la). These results
were not due to a failure of the BCECF detection system to
register acidic pH values in uremic cells since the addition of
the protonophore nigericin at the end of all experiments re-
sulted in detectable cytoplasmic acidification. The results for a
given patient were consistent when tested several weeks later
(coefficient of variation less than 10%).
The abnormal pH response seen in uremic PMN was repro-
duced in normal control cells by a short preincubation for five
minutes at 37°C in a 1:2 dilution of uninfected four-hour dwell
dialysis effluent drained from CAPD patients (PDE). Incubation
in PDE had no significant effect upon the resting pH of cells
(Table 2). Such PDE treated cells demonstrated absent cyto-
plasmic acidification and enhanced alkalinization after FMLP
stimulation (P < 0.001 at 30 seconds and P < 0.01 at 140
seconds after FMLP stimulation compared to controls, Fig. lb).
Using PMN from a single donor and dilutions of a single PDE,
a dose response relationship was obtained for the effect of PDE
treatment upon FMLP-induced cytoplasmic pH changes. Neu-
trophil incubation in PDE as described did not decrease cell
viability assessed by Trypan blue exclusion. The pH and
osmolality of buffer containing PDE was not significantly dif-
ferent from that of buffer alone. Cytoplasmic pH changes in
normal PMN were unaffected by incubation in a similar dilution
of unused, sterile peritoneal dialysis fluid (pH corrected to 7.4
using dilute NaOH).
Stimulated superoxide production and intracellular calcium
release in uremic PMN
The acidification phase of the cytoplasmic pH response in
FMLP treated PMN has been associated with respiratory burst
activity; the two display temporal correlation and both are
absent in PMN from patients with chronic granulomatous
disease which lack functional NADPH oxidase activity [281. A
defective respiratory burst may therefore result in abnormali-
ties of both bacterial killing and cytoplasmic pH in stimulated
PMN. We examined respiratory burst activity in PMN from
uremic patients.
The stimulated level of superoxide production was consis-
tently enhanced in ESRF and CAPD cells compared to controls
(P < 0.05, Fig. 2). Preincubation of normal PMN in PDE as
described above was associated with enhanced superoxide
production. The PDE dilution had no effect upon cell viability
or the buffer as described above. Superoxide production in
normal PMN was unaffected by incubation in a similar dilution
of unused, sterile peritoneal dialysis fluid (pH corrected to 7.4
using dilute NaOH).
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Fig. 1. The abnormal cytoplasmic pH changes stimulated by I si FMLP in (A) PMN from ESRF and CAPD patients and (B) PDE treated normal
PMN compared to controls. Symbols in A are: (•) control N = 24; (0) ESRF N = 14; (D) CAPD N = 11. Symbols in B are: (•) control N =
24; (0) +PDE N = 22. Results are presented with the basal pH normalized to zero and expressed as the mean SEM. Preincubation of normal
control PMN in unused peritoneal dialysis fluid had no effect upon their pH response. P < 0.05 for uremic cells compared to controls at time points
between 20 and 40 seconds and at 140 seconds; P < 0.05 for CAPD cells compared to ESRF at 20 seconds after stimulation.
Other authors have related the cytoplasmic acidification seen
after FMLP stimulation to increases in intracellular calcium;
the two are temporally correlated and abolition of the increase
in calcium levels using intracellular chelators results in loss of
cytoplasmic acidification [261. We therefore examined intracel-
lular calcium release in PMN from uremic patients.
Basal levels of intracellular calcium were similar in control
and uremic PMN. The magnitude and kinetics of the calcium
spike after FMLP stimulation were not significantly different in
control and uremic PMN. Normal PMN preincubated in PDE as
described above demonstrated a normal calcium spike although
a trend towards increased resting calcium levels was seen(P >
0.05, not significant, Fig. 3). Calcium measurements in normal
PMN were unaffected by incubation in a similar dilution of
unused, sterile peritoneal dialysis fluid (pH corrected to 7.4
using dilute NaOH).
Sodium hydrogen antiport activity in uremic PMN
The abnormal pH response seen in uremic PMN may result
from masking the normal acidification by enhanced alkaliniza-
tion rather than absence of a factor which normally produces
acidification. The alkalinization phase of the FMLP stimulated
changes in cytoplasmic pH is sodium dependent since it is
abolished under sodium free conditions, and is normally asso-
ciated with activity of the plasma membrane Na:H antiport and
hence inhibited by amiloride or its analogues [25]. Hexameth-
ylene amiloride (HMA) is a potent and specific Na:H antiport
inhibitor (K1 0.16 tiM) which has been shown to completely
A B
aC
a0)a
E0I0.
C
a0)Ca
0
0.1
0.10
aC
a0)a
.0
E0I0.
C
a0)Ca0
-0.1
50 100 150 200
—0.10
50 100
30
Co
Co0
C CEo
0E
U-
V U..
C Co (I)w
wa
a-
Fig. 2. Enhanced FMLP stimulated superoxide production by PMN
from uremic patients and PDE-treated normal PMN. Each observation
was recorded in duplicate and is presented as the mean SEM of the
number of subjects in parentheses. Preincubation of normal control
PMN in unused peritoneal dialysis fluid had no effect upon their
superoxide responses. P < 0.05 for uremic cells compared to controls.
inhibit neutrophil antiport activity at micromolar concentra-
tions [29], Normal PMN preincubated with HMA for five
minutes at 37°C demonstrated an abnormal cytoplasmic pH
response after FMLP stimulation (Fig. 4). The initial transient
acidification was replaced by a progressive acidification and the
alkalinization phase was absent. Uremic PMN when similarly
treated displayed progressive acidification, although to a lesser
extent than in normal cells. Normal cells incubated in a 1:2
dilution of PDE for five minutes and then incubated with HMA
for five minutes before stimulation with FMLP also demon-
strated progressive cytoplasmic acidification with loss of the
progressive alkalinization phase seen after incubation with PDE
alone (Fig. 4).
Further study of alkalinization mechanisms in uremic PMN
was performed by analysis of the rate of recovery from an
imposed acid load. Measurement of buffering capacity under
bicarbonate free conditions demonstrated significantly in-
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Fig. 3. Normal FMLP stimulated intracellular calcium release by
PMN from uremic patients and PDE treated normal PMN. Symbols
are: (Lii) basal Ca; () Ca post-stimulation by FMLP. Data are
presented as the mean SEM of the number of subjects in parentheses.
The kinetics of the calcium spike in uremic cells were normal. Prein-
cubation of normal control PMN in unused peritoneal dialysis fluid had
no effect upon their resting calcium levels or the calcium spike
generated by I /LM FMLP.
creased values in uremic compared to control PMN at cytoplas-
mic pH values of 6.8 or above (Fig. 5). The kinetic curve
demonstrating the relationship between Na/H antiport activity
and cytoplasmic pH was generated by plotting the product of
buffering capacity and the change in intracellular pH over the
first 30 seconds after acid loading against the starting cytoplas-
mic pH [18]. It can be seen from Figure 6 that the curves for
normal and uremic PMN were not significantly different, and
both were concave with activity increasing as cytoplasmic pH
fell. Since the buffering capacity of uremic PMN was increased,
given the normal Na/H antiport kinetics, the measured change
in initial cytoplasmic pH recovery after acid loading was lower
than that seen in control PMN. In the absence of extracellular
sodium no recovery from acid loading occurred in uremic cells,
indicating a sodium dependent mechanism (Fig. 7).
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Intracellular pH
Fig. 5. Intracellular buffering power of control () and ESRF (El)
neutrophils at dft'erent intracellular pH levels. The buffering power was
evaluated by exposing the cells to 5 mr'i NH4CI and expressed in fliM
H/pH unit. Results from 39 observations on control cells and 56
observations on ESRF cells are presented as mean SEM. The
buffering power of ESRF cells is significantly greater than that of
controls at values of intracellular pH above 6.8 (P < 0.05 compared to
controls).
Comparison of the extent of pH recovery over the initial 30
seconds after acid loading in paired PMN samples at the same
starting pH demonstrated no difference in the presence or
absence of bicarbonate for normal PMN (mean increase 0.262
Fig. 4. Effect of the amiloride analogue HMA
(JO tM) upon the FMLP stimulated pH
response of normal, PDE treated normal and
ESRF PMN. Data are presented as the mean
SEM of the number of at least 4 subjects for
each group. Symbols are: (I) control; (•)
control + HMA; (U), control + PDE; (X)
control + PDE + HMA; (A) ESRF + HMA;
(X) ESRF.
0.034 compared to 0.239 0.038 pH U/30 seconds respectively,
N = 20, P > 0.05 compared each pair with or without
bicarbonate). In contrast, uremic PMN demonstrated greater
pH recovery over 30 seconds in the presence of bicarbonate
(0.205 0.023 compared to 0.121 0.013, N = 30, P < 0.05
comparing each pair with or without bicarbonate).
Discussion
Uremic patients are susceptible to pyogenic infection, but the
mechanisms which predispose them to this remain uncertain.
Since phagocytic cells play an important role in the normal host
defence mechanisms which protect against bacterial infection,
it has been suggested that the function of these cells is defective
in uremia. The neutrophil is the most commonly studied phago-
cytic cell in uremic patients, but unfortunately the literature
concerning the integrity of a variety of PMN functions contains
many conflicting reports [reviewed in 4]. Some of this confusion
is generated by the heterogeneous nature of the populations
studied; PMN are activated to a varying extent by contact with
different dialysis membranes which will complicate any study in
hemodialysis patients, and factors such as drug therapy or the
underlying disorder causing the renal failure may influence
PMN function. The use of different methodologies to study a
given PMN function may result in further confusion [30]. For
example, the intracellular killing of ingested bacteria has been
reported to be normal or reduced in uremic PMN [31, 321.
Accurate measurement of this PMN function requires a method
which is independent of the rate of phagocytosis, and since
different bacterial species display variable sensitivity to PMN
killing mechanisms, comparison between workers using differ-
ent test organisms may not be valid. Nonetheless, methods
0.4
0.2
0.0
—0.2
—0.4
—0.6
I
a)
0)(0
0)
C
0)C)C(0
0
0)
0a-
C)C
0)
0 50 100 150 200
Time, seconds
6.817.06.6—6.8 >7.0
696 Haynes èt al: pH changes in urernic neutrophils
Fig. 6. Activation of the Na:H antiport by
intracellular pH in ESRF (0) and control (•)
PMN. The initial velocity of recovery from
acid loading was obtained for each starting pH
from the product of the pH change over 30
seconds and the intracellular buffering
capacity measured at the same starting pH on
the same sample of cells. Results are
presented for 39 observations on control cells
and 56 observations on ESRF cells, and are
expressed in m H/liter cells/30 seconds.
Both curves demonstrate concavity in keeping
7.4 with the reported properties of the antiport,
but ESRF cells behaved no differently from
control cells.
which meet these technical considerations have reported de-
creased intracellular killing of bacteria in uremic PMN and
peritoneal macrophages from CAPD patients [9, 331. Such a
defect if present in vivo would be relevant to infection in uremic
patients. Neutrophil killing requires the integrity of a number of
cell functions such as adhesion, chemotaxis, phagocytosis and
degranulation [101. In turn, these functions require normal
changes in cell biochemistry and well characterized techniques
are described to measure these events in vitro. The changes in
intracellular calcium, superoxide release and cytoplasmic pH
which accompany activation in normal PMN are therefore well
described, and we have investigated the integrity of these
responses in uremic PMN.
The resting level of intracellular calcium was not significantly
different from normal in PMN from ESRF or CAPD patients.
Similarly, the magnitude and kinetics of the rise in calcium
accompanying stimulation with the chemoattractant FMLP
were not different from normal in ESRF or CAPD patients. The
values for the control PMN were similar to those published by
many other authors using FMLP stimulated Fura 2 loaded PMN
134, 35]. We are unaware of previous reports in the literature
concerning the integrity of this response in PMN from uremic
patients. These results suggest that those enzymes and intra-
cellular events activated by a rise in intracellular calcium should
be intact in PMN from uremic patients. The release of intracel-
lular calcium by FMLP requires normal receptor expression,
activity of a G protein and phospholipase C activity to generate
inositol triphosphate [361. The integrity of the calcium response
to FMLP in uremic PMN may therefore indicate that these
parts of the signal transduction mechanism are intact in these
cells.
The extracellular superoxide release stimulated by FMLP
was enhanced in PMN from both ESRF and CAPD patients.
The literature contains many conflicting reports concerning the
integrity of the respiratory burst hence superoxide release in
uremic PMN and many of the criticisms mentioned above are
also pertinent. For example, decreased levels of luminol en-
hanced chemiluminescence have been reported in response to a
variety of stimuli in uremic PMN and this has been presented as
evidence of impaired respiratory burst activity in these cells
[37, 38]. Unfortunately, luminol chemiluminescence depends in
part upon myeloperoxidase released by primary degranulation,
hence reduced signals using this method may be the result of
either decreased respiratory burst activity, impaired degranu-
lation or both. Direct measurement of superoxide release using
an oxygen electrode is a more sensitive technique for detecting
the PMN respiratory burst and a recent report using this
method has confirmed the enhanced respiratory burst activity
of PMN from ESRF patients [391. This observation indicates
that the supply of substrate for the oxidative killing mechanisms
of uremic PMN is intact.
The sequence of cytoplasmic pH changes which accompany
FMLP stimulation was abnormal in PMN from uremic patients;
the initial acidification was reduced and consequently followed
by increased alkalinization. This could be the result of differ-
ences in the buffering capacity of uremic compared to normal
PMN, absence from uremic PMN of factors responsible for
generating acidification, enhancement in uremic PMN of factors
.
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Fig. 7. Recovery from acid loading in ESRF neutrophils is sodium
dependent. ESRF cells were incubated in HBSS in which NaCI was
isosmotically replaced by choline chloride. After addition of I sM
nigericin at time zero, cytoplasmic acidification was observed. After
scavenging the nigericin with 5 mg/mI bovine serum albumin, no
recovery from acid loading was observed. Data are presented as mean
SEM of four ESRF patients.
responsible for generating alkalinization or a combination of
these factors. The cytoplasmic buffering capacity of uremic
PMN was greater than that of control PMN at pH values of 6.8
or above, and this may protect the patients from acid loading.
The factors responsible for the initial acidification seen in
normal PMN remain controversial. The absence of this phase
from the PMN of patients with chronic granulomatous disease,
a condition in which the NADPH oxidase enzyme responsible
for the respiratory burst is not functional, has been cited as
evidence that NADPH oxidase activity contributes to the
acidification phase [28]. This evidence has been refuted by
other authors who suggest instead that the rise in intracellular
calcium accompanying stimulation is responsible for cytoplas-
mic acidification [261. In uremic PMN we have demonstrated
that both the respiratory burst and calcium spike are intact after
FMLP stimulation, hence absence of these factors is unlikely to
explain their abnormal pH response. Our data cannot exclude
the absence from uremic PMN of other factors which contribute
to the acidification in normal cells. The cytoplasmic alkaliniza-
tion which follows stimulation in normal PMN is largely due to
the activity of a plasma membrane Na:H antiporter since it is
abolished by amiloride or removal of extracellular sodium.
Antiport activity is regulated by cytoplasmic pH in a variety of
tissues 140, 411. This relationship was confirmed in both control
and uremic PMN by the concave activation curve, however, no
difference was present in the cytoplasmic pH-dependent activ-
ity of the antiport in uremic and control PMN. The abnormal
pH response of uremic PMN after FMLP stimulation cannot be
explained by altered Na:H antiport kinetics, although alter-
ations in antiport expression in uremic PMN cannot be ex-
cluded by our data. Inhibition of antiport activity by the specific
inhibitor HMA failed to remove the difference in cytoplasmic
pH after FMLP stimulation in uremic and control PMN. Mech-
anisms other than the antiport may therefore be responsible for
the abnormal pH response seen in uremic cells. Sodium depen-
dent and independent anion exchangers have also been de-
scribed in the PMN plasma membrane, and under certain
conditions these may contribute to cytoplasmic alkalinization
[42]. The recovery from acid loading in uremic PMN was
sodium dependent and, unlike control PMN, was enhanced in
the presence of bicarbonate suggesting the importance of a
sodium and bicarbonate transporter. Further study of anion
exchange mechanisms in uremic PMN is indicated.
Cytoplasmic pH can influence many biochemical reactions
relevant to PMN function. For example, the activity of the
enzyme 5 lipoxygenase is pH sensitive and the release by
stimulated PMN of one of its products, leukotriene B4, a potent
mediator which enhances the respiratory burst,is dependent
upon cytoplasmic alkalinization [29]. We are unaware of previ-
ous reports examining the cytoplasmic pH changes in stimu-
lated uremic PMN. The abnormal pH response of uremic PMN
may relate to functional defects, and further study of its
relationship to degranulation and the miroenvironment of the
phagocytic vacuole are relevant to intracellular killing by ure-
mic PMN.
We have previously demonstrated the presence of defective
killing in PMN from CAPD patients, and the appearance of
factors which impair bacterial killing by normal PMN in PDE
during a four-hour dwell time [9]. In these experiments we have
demonstrated that short incubations in four-hour dwell PDE
produce biochemical defects in normal PMN consistent with
those present in uremic cells. The enhancement of superoxide
release by factors in PDE has previously been reported, but we
are unaware of publications concerning its effect upon the
calcium and pH responses of PMN. These observations are
relevant to the pathogenesis of peritonitis in CAPD patients
where the intracellular survival of bacteria within PMN present
in infected PDE has been clearly demonstrated [43]. Controling
experiments using PDE is difficult; it is not possible to obtain
fluid from the peritoneum of non-anesthetised normal controls,
and interspecies variation in PMN physiology can make animal
models difficult to interpret. In our experiments care was taken
to exclude nonspecific effects of the pH or osmolality of PDE
upon PMN, and the controls with unused dialysis fluid indicate
that the factors influencing PMN function require interaction
between fluid and the peritoneum. At the short incubation times
employed in these experiments, the effects of PDE are unlikely
to be due to endotoxin contamination. Preliminary characteri-
zation of the factors in PDE which influence PMN function
indicate the involvement of a non-protein molecule of a molec-
ular weight less than 1500 Da; further characterization is in
progress. Characterization is required before the factor in PDE
producing defective PMN functions can be identified as the
circulating toxin impairing circulating PMN function in uremia.
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Abnormal PMN function may be relevant to the pathogenesis
of infection in uremic patients. This study indicates the need for
further investigation of the influence of uremia upon these cells.
Moreover, since the biochemistry and physiology of normal
PMN is well described, abnormalities in uremic PMN may
provide insight into the mechanism of dysfunction in other
uremic tissues.
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Appendix. Abbreviations
BCECF, 2,7-bis(2 carboxyethyl)-5 ,(6)-carboxyfluorescein
CAPD, continuous ambulatory peritoneal dialysis
DMSO, dimethylsulphoxide
EDTA, ethylenediaminetetra-acetic acid
ESRF, end-stage renal failure
FMLP, formylmethionyl leucyiphenylalanine
HBSS, Hank's balanced salt solution
HMA, hexamethylene amioride
PBS, phosphate buffered saline
PDE, effluent peritoneal dialysis fluid
PMN, polymorphonuclear neutrophil
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